Literature DB >> 33646398

Rickets, elevated fibroblast growth factor-23 and mild anemia: Answers.

Judith Sebestyen VanSickle1, Tarak Srivastava2, Penny Monachino2, Uri S Alon2.   

Abstract

Entities:  

Keywords:  ADHR; Autosomal dominant hypophosphatemic rickets; Child; FGF23 mutation; Hypophosphatemic rickets; Iron deficiency

Year:  2021        PMID： 33646398     DOI： 10.1007/s00467-021-05012-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  7 in total

1.  Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.

Authors:  Erik A Imel; Munro Peacock; Amie K Gray; Leah R Padgett; Siu L Hui; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2011-08-31       Impact factor: 5.958

Review 2.  Hypophosphatemic Rickets.

Authors:  Martin Bitzan; Paul R Goodyer
Journal:  Pediatr Clin North Am       Date:  2019-02       Impact factor: 3.278

Review 3.  The role of FGF23 in CKD--with or without Klotho.

Authors:  Hirotaka Komaba; Masafumi Fukagawa
Journal:  Nat Rev Nephrol       Date:  2012-06-19       Impact factor: 28.314

4.  Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

Authors:  Shiguang Liu; Wen Tang; Jianping Zhou; Jason R Stubbs; Qiang Luo; Min Pi; L Darryl Quarles
Journal:  J Am Soc Nephrol       Date:  2006-04-05       Impact factor: 10.121

5.  Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets.

Authors:  E M Eicher; J L Southard; C R Scriver; F H Glorieux
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

6.  Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.

Authors:  Connor Francis; Guillaume Courbon; Claire Gerber; Samantha Neuburg; Xueyan Wang; Corey Dussold; Maralee Capella; Lixin Qi; Tamara Isakova; Rupal Mehta; Aline Martin; Myles Wolf; Valentin David
Journal:  Kidney Int       Date:  2019-08-30       Impact factor: 10.612

7.  Oral Iron for Prevention and Treatment of Rickets and Osteomalacia in Autosomal Dominant Hypophosphatemia.

Authors:  Wolfgang Högler; Klaus Kapelari
Journal:  J Bone Miner Res       Date:  2019-12-31       Impact factor: 6.741
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.